Please assess the completion status of the following clinical trial:

Trial Title: RAndomized Controlled Trial of a Multiple INtervention proGram to Decrease Heart Failure Rehospitalization

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: SUPPORTIVE_CARE
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Heart decompensation requiring hospitalization and the use of intravenous diuretic therapy~* Left Ventricular Ejection Fraction ≤ 40%.~Exclusion Criteria:~* Hospitalization for cardiac decompensation leading to an invasive procedure (valve, coronary, etc.).~* Acute reversible cause of heart failure.~* Incurable disease (other than heart failure) or estimated life expectancy of less than one year.~* Patient transferred directly to another department or cardiac rehabilitation center.~* Significant cognitive impairment.~* Patient without cell phone or email.~* Linguistic or psychic refusal or inability to sign the informed consent.~* Current participation in a clinical tria

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 85 Years
- Healthy Volunteers: f

Study Arms:
- multi-intervention (Type: EXPERIMENTAL): * Automatic creation of discharge prescription (personalized checklist of possible therapeutic optimizations generated from clinical data entered into the platform. This checklist will comply with the recommendations on altered left ventricular ejection fraction from European Society of Cardiology 2016.~* Automatic creation of documents for patient:~  * Reminder letter to make an appointment with his general practitioner (at 7 days) and cardiologist (1 month) and to report the prescribed blood test.~ * Drug prescription.~ * Prescription for blood tests (5 days and 25 days before seeing the general practitioner and cardiologist).~ * Therapeutic education documents~* Patients will receive numerous messages (SMS / e-mail) in order to 1 / not forget their medical appointments, 2 / not to forget to make and bring back their blood test for the consultation, 3 / to perfect the therapeutic education advice provided previously
- Control (Type: NO_INTERVENTION): Discharge prescription according to the investigator's habits.

Based on this trial design, predict the completion outcome and termination type (if applicable).